This week in Other Barks & Bites: the European Commission fines Teva Pharmaceutical $503 million for misusing the patent system to block competition to its multiple sclerosis drug; former USPTO Director Andrei Iancu endorses Donald Trump for President; and a study finds tech giants and the semiconductor industry are leading patent growth.
Recent Posts
- IP as a Force for Good: A Conversation with WIPO Director General Daren Tang
- Stewart Defends Hands-On Approach as Squires Confirmation Looms
- Former USPTO Solicitor Urges Squires Confirmation, Accuses Acting Director of Overreach
- Other Barks & Bites for Friday, September 12: Novartis Loses Challenge to IRA Drug Price Negotiation Program; Lutnick Wants a Share of University IP Licensing; and EUIPO Announces First Copyright Conference
- Government Taking a Cut of University Royalties Would Threaten Bayh-Dole’s ROI